title: Immunoliposome-mediated targeting of anti-cancer drugs in vivo.
authors.affiliation: Department of Pharmacology, University of Alberta, Edmonton, Canada.
authors.forename: T M
authors.initials: TM
authors.lastname: Allen
authors.forename: I
authors.initials: I
authors.lastname: Ahmad
authors.forename: D E
authors.initials: DE
authors.lastname: Lopes de Menezes
authors.forename: E H
authors.initials: EH
authors.lastname: Moase
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D018796:Immunoconjugates / Q000008:administration & dosage*; D008081:Liposomes; D008175:Lung Neoplasms / Q000188:drug therapy; D016393:Lymphoma, B-Cell / Q000188:drug therapy; D051379:Mice; D008807:Mice, Inbred BALB C; D008811:Mice, Inbred DBA; D008819:Mice, Nude; D016513:Mice, SCID; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D018796:Immunoconjugates; D008081:Liposomes; D004317:Doxorubicin